| By Maya Goldman |
![]() |
| Illustration: Sarah Grillo/Axios |
| Traditional Medicare is requiring more pre-treatment approvals in a bid to root out unnecessary care.
The big picture: Medicare’s fee-for-service program hasn’t required prior authorizations to access most drugs or services, a major perk for enrollees.
State of play: Medicare’s innovation center announced on Friday that it will solicit applications from companies to run the prior authorization program starting Jan. 1.
The change will apply to 17 items and services, including skin substitutes, deep brain stimulation for Parkinson’s disease, impotence treatment and arthroscopy for knee osteoarthritis.
Zoom in: The companies hired to manage the program will be paid based on how much they save the government by stopping payments for unnecessary services. Read the rest |

